Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 17, 2024 - Issue
Submit an article Journal homepage
21
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH LETTER

Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry

Nijra L Lugogo1 University of Michigan Medical School, Ann Arbor, MI, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0235-7105View further author information
ORCID Icon,
Enrico Heffler2 IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy;3 Humanitas University, Pieve Emanuele, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-0492-5663View further author information
ORCID Icon,
Vicente Plaza4 Hospital de la Santa Creu i Sant Pau, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0003-2567-5496View further author information
ORCID Icon,
Ole Hilberg5 Lillebaelt Hospital, Vejle, DenmarkORCID Iconhttps://orcid.org/0000-0002-3075-3463View further author information
ORCID Icon,
Changming Xia6 Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAORCID Iconhttps://orcid.org/0000-0002-5703-5074View further author information
ORCID Icon,
Scott Nash6 Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAView further author information
,
Nami Pandit7 Sanofi, Bridgewater, NJ, USAORCID Iconhttps://orcid.org/0000-0002-1072-2897View further author information
ORCID Icon,
Juby A Jacob-Nara7 Sanofi, Bridgewater, NJ, USAORCID Iconhttps://orcid.org/0000-0002-5372-8762View further author information
ORCID Icon,
Harry J Sacks6 Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAORCID Iconhttps://orcid.org/0000-0002-8191-2866View further author information
ORCID Icon,
Paul J Rowe7 Sanofi, Bridgewater, NJ, USAView further author information
,
Yamo Deniz6 Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAORCID Iconhttps://orcid.org/0000-0003-1655-5628View further author information
ORCID Icon,
Megan Hardin8 Sanofi, Cambridge, MA, USAORCID Iconhttps://orcid.org/0000-0001-7622-9598View further author information
ORCID Icon &
Xavier Soler6 Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAView further author information
 show all
Pages 551-556 | Received 12 Dec 2023, Accepted 22 May 2024, Published online: 07 Jun 2024

References

  • Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence disease burden and options for treatment. Respir Med. 2006;100(7):1139–1151. doi:10.1016/j.rmed.2006.03.031
  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2022. Available from: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf. Accessed May 24, 2024.
  • Macdonald LE, Karow M, Stevens S, et al. Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes. Proc Natl Acad Sci U S A. 2014;111(14):5147–5152. doi:10.1073/pnas.1323896111
  • Murphy AJ, Macdonald LE, Stevens S, et al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci U S A. 2014;111(14):5153. doi:10.1073/pnas.1324022111
  • Gandhi NA, Pirozzi G, Graham NMH. Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert Rev Clin Immunol. 2017;13(5):425–437. doi:10.1080/1744666X.2017.1298443
  • Le Floc’h A, Allinne J, Nagashima K, et al. Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation. Allergy. 2020;75(5):1188–1204. doi:10.1111/all.14151
  • Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486–2496. doi:10.1056/NEJMoa1804092
  • Rabe KF, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475–2485. doi:10.1056/NEJMoa1804093
  • Wechsler ME, Ford LB, Maspero JF, et al. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Lancet Respir Med. 2022;10(1):11–25. doi:10.1016/S2213-2600(21)00322-2
  • Gall R, Jain N, Soong W, et al. Dupilumab-treated patients with asthma in the real world: the RAPID Global Registry. Adv Ther. 2023;40(3):1292–1298. doi:10.1007/s12325-022-2399-5

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.